Drugs / BX1000
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05687253 | Oct 2022 → Apr 2023 | — | Baudax Bio | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BX1000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05687253 ↗ |
| Route | Intravenous | “IV BX1000” NCT05687253 ↗ |